Evaluation of a sensitive copeptin assay for clinical measurement

Open Clinical Chemistry Journal

Volumn 5, Issue 1, 2012, Pages 21-26

  Terzic, D ^a   Johansson Fallgren A S ^b   Ragnarsson, O ^b   Goetze, J P ^a   Hammarsten, O ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Copeptin; Diabetes insipidus; Heart failure; Myocardial infarction; Vasopressin

Indexed keywords

COPEPTIN; DESMOPRESSIN; GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE; REAGENT; TESTOSTERONE;

ACCURACY; ACUTE HEART INFARCTION; ADULT; ANALYTICAL EQUIPMENT; ARTICLE; CASE REPORT; CONTAMINATION; CONTROLLED STUDY; CUSHING DISEASE; DIABETES INSIPIDUS; ENDOCRINE SURGERY; FEMALE; FLUID INTAKE; FREEZE THAWING; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; HYPERNATREMIA; HYPOPITUITARISM; LABORATORY; LIMIT OF DETECTION; MALE; NONFUNCTIONING PITUITARY ADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; PLASMA; POLYURIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS;

EID: 84871022052     PISSN: None     EISSN: 18742416     Source Type: Journal    
DOI: 10.2174/1874241601205010021     Document Type: Article

References (25)

1. Morgenthaler, N.G.; Struck, J.; Alonso, C.; Bergmann, A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin. Chem., 2006, 52(1), 112-9.
2. Morgenthaler, N.G.; Struck, J.; Jochberger, S.; Dunser, M.W. Co-peptin: clinical use of a new biomarker. Trends Endocrinol. Me-tab,. 2008, 19(2), 43-9.
3. Hammarsten, O.; Goetze, J.P. Copeptin: A new peptide in clinical measurement. Klinisk Biokemi i Norden, 2012, 1, 22-7.
4. Fenske, W.; Quinkler, M.; Lorenz, D.; Zopf, K.; Haagen, U.; Papassotiriou, J.; Pfeiffer, A.F.; Fassnach, M.; Stork, S.; Allolio, B. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests. J. Clin. Endocrinol. Metab., 2011, 96(5), 1506-15.
5. Giannitsis, E.; Kehayova, T.; Vafaie, M.; Katus, H.A. Combined testing of high-sensitivity troponin t and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-st-segment ele-vation myocardial infarction. Clin. Chem., 2011, 57(10), 1452-5.
6. Staub, D.; Morgenthaler, N.G.; Buser, C.; Breidthardt, T.; Potocki, M.; Noveanu, M.; Reichlin, T.; Bergmann, A.; Mueller, C. Use of copeptin in the detection of myocardial ischemia. Clin. Chim. Acta, 2009, 399(1-2), 69-73.
7. Reichlin, T.; Hochholzer, W.; Stelzig, C.; Laule, K.; Freidank, H.; Morgenthaler, N.G.; Bergmann, A.; Potocki, M.; Noveanu, M.; Breidthardt, T.; Christ, A.; Boldanova, T.; Merki, M.; Schaub, N.; Bingisser, R.; Christ, M.; Mueller, C. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J. Am. Coll. Car-diol., 2009, 54(1), 60-8.
8. Keller, T.; Tzikas, S.; Zeller, T.; Czyz, E.; Lillpopp, L.; Ojeda, F.M.; Roth, A.; Bickel, C.; Baldus, S.; Sinning, C.R.; Wild, P.S.; Lubos, E.; Peetz, E.; Kunde, J; Hartmann, O.; Bergmann, A.; Post, F.; Lackner, K.J.; Genth-Zotz, S.; Nicaud, V.; Tiret, L; Munzel, T.F.; Blankenberg, S. Copeptin improves early diagnosis of acute myocardial infarction. J. Am. Coll. Cardiol., 2010, 55(19), 2096-106.
9. Meune, C.; Zuily, S.; Wahbi, K.; Claessens, Y.E.; Weber, S.; Chenevier-Gobeaux, C. Combination of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction: a pilot study. Arch. Car-diovasc. Dis., 2011, 104(1), 4-10.
10. Gu, Y.L.; Voors, A.A.; Zijlstra, F.; Hillege, H.L.; Struck, J.; Masson, S.; Vago, T.; Anker, S.D.; van den Heuvel, A.F.; van Veldhuisen, D.J.; de Smet, B.J. Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial in-farction. Clin. Res. Cardiol., 2011, 100(12), 1069-76.
11. Narayan, H.; Dhillon, OS.; Quinn, P.A.; Struck, J.; Squire, I.B.; Davies, J.E.; Ng, LL. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarc-tion: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study. Clin. Sci. (Lond.), 2011, 121(2), 79-89.
12. Alehagen, U.; Dahlstrom, U.; Rehfeld, J.F.; Goetze, J.P. Associa-tion of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart fail-ure. JAMA, 2011, 305(20), 2088-95.
13. Voors, A.A.; von Haehling, S.; Anker, S.D.; Hillege, H.L.; Struck, J.; Hartmann, O.; Bergmann, A.; Squire, I.; van Veldhuisen, D.J.; Dickstein, K.; OPTIMAAL Investigators. C-terminal provaso-pressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Eur. Heart. J., 2009, 30(10), 1187-94.
14. Tentzeris, I.; Jarai, R.; Farhan, S.; Perkmann, T.; Schwarz, M.A.; Jakl, G.; Wojta, J.; Huber, K. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with sta-ble chronic heart failure. Eur. J. Heart. Fail., 2011, 13(7),726-33.
15. Stoiser, B.; Mortl, D.; Hulsmann, M.; Berger, R.; Struck, J.; Morgenthaler, N.G.; Bergmann, A.; Pacher, R. Copeptin, a frag-ment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eu. r J. Clin. Invest., 2006, 36(11), 771-8.
16. Maisel, A.; Xue, Y.; Shah, K.; Mueller, C.; Nowak, R.; Peacock, W.F.; Ponikowski, P.; Mockel, M.; Hogan, C.; Wu, A.H.; Richards, M.; Clopton, P.; Filippatos, G.S.; Di Somma, S.; Anand, I.S.; Ng, L.; Daniels, L.B.; Neath, S.X.; Christenson, R.; Potocki, M.; McCord, J.; Terracciano, G.; Kremastinos, D.; Hartmann, O.; von Heahling, S.; Bergmann, A.; Morgenthaler, N.G.; Anker, S.D. In-creased 90-Day Mortality in Acute Heart Failure Patients with Ele-vated Copeptin: Secondary Results from the Biomarkers in Acute Heart Failure (BACH) Study. Circ. Heart. Fail., 2011, 4(5), 613-20.
17. Seligman, R.; Papassotiriou, J.; Morgenthaler, N.G.: Meisner, M.; Teixeira, P.J. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit. Care, 2008, 12(1), R11.
18. Russell, J.A. Vasopressin and its copilot copeptin in sepsis and septic shock. Crit. Care. Med., 2009, 37(2), 749-50.
19. Jochberger, S.; Dorler, J.; Luckner, G.; Mayr, V.D.; Wenzel, V.; Ulmer, H.; Morgenthaler, N.G.; Hasibeder, W.R.; Dunser, M.W. The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit. Care Med., 2009, 37(2), 476-82.
20. Urwyler, S.A.; Schuetz, P.; Fluri, F.; Morgenthaler, N.G.; Zweifel, C.; Bergmann, A.; Bingisser, R.; Kappos, L.; Steck, A.; Engelter, S.; Muller, B.; Christ-Crain, M.; Katan, M. Prognostic value of co-peptin: one-year outcome in patients with acute stroke. Stroke, 2010, 41(7), 1564-7.
21. Katan, M.; Fluri, F.; Morgenthaler, N.G.; Schuetz, P.; Zweifel, C.; Bingisser, R.; Muller, M.; Meckel, S.; Gass, A.; Kappos, L.; Steck, A.J.; Engelter, S.T.; Muller, B.; Christ-Crain, M. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann. Neurol., 2009, 66(6), 799-808.
22. Kleindienst, A.; Brabant, G.; Morgenthaler, N.G.; Dixit, K.C.; Parsch, H.; Buchfelder, M. Following brain trauma, copeptin, a stable peptide derived from the AVP precusor, does not reflect os-moregulation but correlates with injury severity. Acta Neurochir. Suppl. 2010, 106, 221-4.
23. Dong, X.Q.; Huang, M.; Yang, S.B.; Yu, W.H.; Zhang, Z.Y. Co-peptin is associated with mortality in patients with traumatic brain injury. J. Trauma, 2011, 71(5), 1194-8.
24. Antonescu-Turcu, A.L.; Tomic, R. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease ex-acerbations. Curr. Opin. Pulm. Med., 2009, 15(2), 120-5.
25. Thygesen, K.; Alpert, J.; White, H.; Jaffe, A.; Apple, F.; Galvani, M. Universal definition of myocardial infarction. Circulation, 2007, 116(22), 2634-53.